Subspecific differentiation of Burkholderia cepacia isolates in cystic fibrosis

Journal of Medical Microbiology

Volumn 47, Issue 11, 1998, Pages 999-1006

  Livesley, M A ^a   Baxter, I A ^a   Lambert, P A ^a   Govan, J R W ^b   Weller, P H ^c   Lacey, D E ^d   Allison, D G ^e   Giwercman, B ^f   Hoiby, N ^f  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d Wirral Hospital   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DENMARK; GENOTYPE; HUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; UNITED KINGDOM;

EID: 0031795798     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-47-11-999     Document Type: Article

References (37)

1. LiPuma JJ, Marks-Austin KA, Holsclaw DS, Winnie GB, Gilligan PH, Stull TL. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J 1994; 13: 716-719.
2. Govan JRW, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996; 60: 539-574.
3. Lacy DE, Spencer DA, Goldstein A, Weller PH, Darbyshire P. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia. J Infect 1993; 27: 301-304.
4. Verghese A, Al-Samman M, Nabhan D, Naylor AD, Rivera M. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection. Arch Intern Med 1994; 154: 2086-2091.
5. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996; 143: 1007-1017.
6. Mortensen JE, Fisher MC, LiPuma JJ. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol 1995; 16: 30-32.
7. Butler SL, Doherty CJ, Hughes JE, Nelson JW, Govan JRW. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol 1995; 33: 1001-1004.
8. Hobson R, Gould I, Govan JWR. Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media. Eur J Clin Microbiol Infect Dis 1995; 14: 908-911.
9. Govan JWR, Nelson JW. Microbiology of cystic fibrosis lung infections: themes and issues. J R Soc Med 1993; 86 (Suppl 20): 11-18.
10. Govan JWR, Nelson JW. Microbiology of lung infection in cystic fibrosis. Br Med Bull 1992; 48: 912-930.
11. Stableforth DE, Smith DL. Pseudomonas cepacia in cystic fibrosis. Thorax 1994; 49: 629-630.
12. Isles A, Maclusky I, Corey M et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984, 104: 206-210.
13. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990; 330: 1094-1096.
14. Ouchi K, Abe M, Karita M, Oguri T, Igari J, Nakazawa T. Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing. J Clin Microbiol 1995; 33: 2353-2357.
15. Govan JRW, Brown PH, Maddison J et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342: 15-19.
16. Govan JWR, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996; 45: 395-407.
17. Muhdi K, Edenborough FP, Gumery L et al. Outcome for patients colonised with Burkholderia cepacia in Birmingham adult cystic fibrosis clinic and the end of an epidemic. Thorax 1996; 51: 374-377.
18. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Med 1995; 1: 661-666.
19. Ryley HC, Ojeniyi B, Hoiby N, Weeks J. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1996; 15: 755-758.
20. Gotoh N, Nagino K, Wada K, Tsujimoto H, Nishino T. Burkholderia (formerly Pseudomonas) cepacia porin is an oligomer composed of two component proteins. Microbiology 1994; 140: 3285-3291.
21. van Alphen L, van Dam A, Bol P, Spanjaard K, Zanen HC. Types and subtypes of 73 strains of Haemophilus influenzae isolated from patients more than 6 years of age with meningitis in the Netherlands. J Infect 1987; 15: 95-101.
22. Parr TR, Moore RA, Moore LV, Hancock REW. Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother 1987; 31: 121-123.
23. Rainey PB, Thompson IP, Palleroni NJ. Genome and fatty acid analysis of Pseudomonas stutzeri. Int J Syst Bacteriol 1994; 44: 54-61.
24. Grothues D, Tümmler B. New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species. Mol Microbiol 1991; 5: 2763-2776.
25. Lugtenberg B, Meijers J, Peters R, van der Hoek P, van Alphen L. Electrophoretic resolution of the 'major outer membrane protein' of Escherichia coli K12 into four bands. FEBS Lett 1975; 58: 254-258.
26. Vandamme P, Holmes B, Vancanneyt M et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis and proposal of Burkholderia multivorans sp nov. Int J Syst Bacteriol 1997; 47: 1188-1200.
27. Lacy DE, Smith AW, Lambert PA et al. Serum IgG response to an outer membrane porin protein of Burkholderia cepacia in patients with cystic fibrosis. FEMS Immunol Microbiol 1997; 17: 87-94.
28. Hancock REW, Mouat ECA, Speert DP. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. J Infect Dis 1984; 149: 220-226.
29. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns producted by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995: 33: 2233-2239.
30. Gaur D, Wilkinson SG. Lipopolysaccharide from Burkholderia vietnamiensis strain LMG 6999 contains two polymers identical to those present in the reference strain for Burkholderia cepacia serogrpup O4. FEMS Microbiol Lett 1997; 157: 183-188.
31. Pitt TL, Kaufmann ME, Patel PS, Benge LCA, Gaskin S, Livermore DM. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 1996; 44: 203-210.
32. Baxter IA, Lambert PA, Simpson IN. Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli. J Antimicrob Chemother 1997; 39: 169-175.
33. Barth AL, Pitt TL. Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol 1995; 33: 2192-2194.
34. Burkholder W. Sour skin, a bacterial rot of onion bulbs. Phytopathology 1950; 40: 115-117.
35. Yohalem DS, Lorbeer JW. Intraspecific metabolic diversity among strains of Burkholderia cepacia isolated from decayed onions, soils, and the clinical environment. Antonie van Leeuwenhoek 1994; 65: 111-131.
36. Yohalem DS, Lorbeer JW. Multilocus isoenzyme diversity among strains of Pseudomonas cepacia isolated from decayed onions, soils, and clinical sources. Syst Appl Microbiol 1994; 17: 116-124.
37. Simpson IN, Finlay J, Winstanley DJ et al. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother 1994; 34: 353-361.